Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma
Abstract Background Neuroblastoma (NB) is an early childhood malignancy that arises from the developing sympathetic nervous system. Harmine is a tricyclic β-carboline alkaloid isolated from the harmal plant that exhibits both cytostatic and cytotoxic effects. Harmine is capable of blocking the activ...
Main Authors: | Katie L. Uhl, Chad R. Schultz, Dirk Geerts, André S. Bachmann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-018-0574-3 |
Similar Items
-
How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition—The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine
by: Anne Wurzlbauer, et al.
Published: (2020-12-01) -
Data supporting a pilot high-throughput screen of a drug library for identification of DYRK1A inhibitors and high-content imaging analysis of identified harmine analogs
by: Michael Tarpley, et al.
Published: (2021-08-01) -
Structure–Activity Relationships and Biological Evaluation of 7-Substituted Harmine Analogs for Human β-Cell Proliferation
by: Kunal Kumar, et al.
Published: (2020-04-01) -
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
by: Mattias F. Lindberg, et al.
Published: (2021-06-01) -
Effect of harmine on nicotine-induced kidney dysfunction in male mice
by: Mohammad Reza Salahshoor, et al.
Published: (2019-01-01)